Market Overview:
The global monoclonal antibody service market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for monoclonal antibodies for research and diagnostic applications, and the growing number of biotechnology and pharmaceutical companies. The global monoclonal antibody service market is segmented on the basis of type, application, and region. On the basis of type, it is divided into reagents, drugs, and other services. Reagents are further classified into polyclonal antibodies and monoclonal antibodies. Drugs are further classified into therapeutic mAbs and diagnostics mAbs. On the basis of application, it is divided into diagnostic laboratories, research & academic laboratories, pharmaceutical & biotechnology companies (P&B), contract manufacturing organizations (CMOs), CROs/clinical trial organizations (CTOs), hospitals & clinics/academic medical centers (AMCs), veterinary clinics/hospitals)and others including forensic labs).
Product Definition:
A monoclonal antibody service is a laboratory process that uses antibodies to detect and identify specific proteins in a sample. The importance of monoclonal antibody services lies in their ability to specifically target and bind to a desired molecule, which can then be used for diagnostic or therapeutic purposes.
Reagents:
Reagents are chemicals or materials that help in enhancing, detecting, or isolating a particular substance. Reagents are used for various applications such as protein purification and detection methods of medical drugs. The global reagents market is expected to witness significant growth over the forecast period owing to its increasing application in diagnostics and drug discovery processes by monoclonal antibody (MAB) service providers.
Drugs:
Monoclonal Antibody Service is a medical service, which provides monoclonal antibodies (MABs) to patients with cancer. The treatment helps the immune system of the patient to recognize and attack cancer cells. Drugs are used by doctors or healthcare professionals for treating diseases or disorders in patients. There are various types of drugs such as antibiotics, painkillers, anti-inflammatory drugs and others which help in curing different diseases like diabetes etc.
Application Insights:
The diagnostic laboratories segment dominated the global monoclonal antibody service market in 2017. This is attributed to a rise in demand for rapid and sensitive tests for infectious diseases, cancer, diabetes and other autoimmune disorders. Moreover, an increase in the prevalence of chronic conditions has led to an increased need for diagnostics that help identify the cause of symptoms rather than just identifying a disease state.
This factor is anticipated to fuel market growth over the forecast period as most companies are focusing on developing products with high specificity and sensitivity which can be used as screening tests or preliminary diagnosis tools.
Regional Analysis:
North America dominated the global monoclonal antibody service market in 2017. This is due to presence of a large number of players, high investment in R&D and availability of reimbursement facilities for patients. In addition, increasing prevalence of cancer and other chronic diseases are also contributing towards the growth in this region. For instance, according to statistics published by American Cancer Society (ACS), Inc., around 2 million new cases were estimated to be diagnosed in U.S. alone during 2016’s year while about 1 million people died from it after a span of one year which accounts for an incidence rate of about 6% among total population over 60 years old living in U.S.
Growth Factors:
- Increasing demand for monoclonal antibodies from the biopharmaceutical and diagnostic industries for the treatment of various diseases
- Growing prevalence of cancer, autoimmune disorders, and other chronic diseases that require monoclonal antibody-based therapies
- Rising public and private investments in research and development of monoclonal antibody-based therapeutics
- Technological advancements in monoclonal antibody production that improve yield, purity, and specificity
- Growth in the number of clinical trials using monoclonal antibodies as therapeutic agents
Scope Of The Report
Report Attributes
Report Details
Report Title
Monoclonal Antibody Service Market Research Report
By Type
Reagents, Drugs, Other
By Application
Diagnostic Laboratories, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies
By Companies
Pfizer, Roche, Eli Lilly, Bayer, Amgen, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Merck, Abbott Laboratories, GSK, BMS, Alexion, UCB, Seattle Genetics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Monoclonal Antibody Service Market Report Segments:
The global Monoclonal Antibody Service market is segmented on the basis of:
Types
Reagents, Drugs, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Laboratories, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Roche
- Eli Lilly
- Bayer
- Amgen
- Sanofi-Aventis
- Johnson & Johnson
- Novo Nordisk
- Merck
- Abbott Laboratories
- GSK
- BMS
- Alexion
- UCB
- Seattle Genetics
Highlights of The Monoclonal Antibody Service Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reagents
- Drugs
- Other
- By Application:
- Diagnostic Laboratories
- Research & Academic Laboratories
- Pharmaceutical & Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Monoclonal Antibody Service Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Monoclonal antibody service is a type of laboratory service that provides custom-made monoclonal antibodies to researchers and clinicians. Monoclonal antibody services are typically used to diagnose or treat diseases, and they can be ordered through a variety of online platforms.
Some of the major companies in the monoclonal antibody service market are Pfizer, Roche, Eli Lilly, Bayer, Amgen, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Merck, Abbott Laboratories, GSK, BMS, Alexion, UCB, Seattle Genetics.
The monoclonal antibody service market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Monoclonal Antibody Service Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Monoclonal Antibody Service Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Monoclonal Antibody Service Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Monoclonal Antibody Service Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Monoclonal Antibody Service Market Size & Forecast, 2018-2028
4.5.1 Monoclonal Antibody Service Market Size and Y-o-Y Growth
4.5.2 Monoclonal Antibody Service Market Absolute $ Opportunity
Chapter 5 Global Monoclonal Antibody Service Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Monoclonal Antibody Service Market Size Forecast by Type
5.2.1 Reagents
5.2.2 Drugs
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Monoclonal Antibody Service Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Monoclonal Antibody Service Market Size Forecast by Applications
6.2.1 Diagnostic Laboratories
6.2.2 Research & Academic Laboratories
6.2.3 Pharmaceutical & Biotechnology Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Monoclonal Antibody Service Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Monoclonal Antibody Service Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Monoclonal Antibody Service Analysis and Forecast
9.1 Introduction
9.2 North America Monoclonal Antibody Service Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Monoclonal Antibody Service Market Size Forecast by Type
9.6.1 Reagents
9.6.2 Drugs
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Monoclonal Antibody Service Market Size Forecast by Applications
9.10.1 Diagnostic Laboratories
9.10.2 Research & Academic Laboratories
9.10.3 Pharmaceutical & Biotechnology Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Monoclonal Antibody Service Analysis and Forecast
10.1 Introduction
10.2 Europe Monoclonal Antibody Service Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Monoclonal Antibody Service Market Size Forecast by Type
10.6.1 Reagents
10.6.2 Drugs
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Monoclonal Antibody Service Market Size Forecast by Applications
10.10.1 Diagnostic Laboratories
10.10.2 Research & Academic Laboratories
10.10.3 Pharmaceutical & Biotechnology Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Monoclonal Antibody Service Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Monoclonal Antibody Service Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Monoclonal Antibody Service Market Size Forecast by Type
11.6.1 Reagents
11.6.2 Drugs
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Monoclonal Antibody Service Market Size Forecast by Applications
11.10.1 Diagnostic Laboratories
11.10.2 Research & Academic Laboratories
11.10.3 Pharmaceutical & Biotechnology Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Monoclonal Antibody Service Analysis and Forecast
12.1 Introduction
12.2 Latin America Monoclonal Antibody Service Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Monoclonal Antibody Service Market Size Forecast by Type
12.6.1 Reagents
12.6.2 Drugs
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Monoclonal Antibody Service Market Size Forecast by Applications
12.10.1 Diagnostic Laboratories
12.10.2 Research & Academic Laboratories
12.10.3 Pharmaceutical & Biotechnology Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Monoclonal Antibody Service Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Monoclonal Antibody Service Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Monoclonal Antibody Service Market Size Forecast by Type
13.6.1 Reagents
13.6.2 Drugs
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Monoclonal Antibody Service Market Size Forecast by Applications
13.10.1 Diagnostic Laboratories
13.10.2 Research & Academic Laboratories
13.10.3 Pharmaceutical & Biotechnology Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Monoclonal Antibody Service Market: Competitive Dashboard
14.2 Global Monoclonal Antibody Service Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Roche
14.3.3 Eli Lilly
14.3.4 Bayer
14.3.5 Amgen
14.3.6 Sanofi-Aventis
14.3.7 Johnson & Johnson
14.3.8 Novo Nordisk
14.3.9 Merck
14.3.10 Abbott Laboratories
14.3.11 GSK
14.3.12 BMS
14.3.13 Alexion
14.3.14 UCB
14.3.15 Seattle Genetics
